Delivery Order SPE2DB24D2013-SPE2DB25FCKCD
- Not listed
- The Defense Logistics Agency awarded a $21,972.38 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TALTZ 80 mg/mL autoinjectors. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of TALTZ 80 mg/ml auto-injector two-packs with a ceiling value of $8,391.13. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $24,342.24 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) units, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,287.82 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 3, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $19,447.53 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of TALTZ 80 MG/ML auto-injector (2-pack) pharmaceutical products. This firm fixed-price delivery order, which concludes on August 15, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $5,392.46 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies. This non-set-aside, firm fixed price delivery order was executed on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication used to treat autoimmune inflammatory...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Auto-Injector with a ceiling value of $6,500.68 under firm fixed pricing. This non-competitive delivery order is scheduled for completion by August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat inflammatory conditions, and the auto-injector formulation provides...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKCDDelivery Order
The Defense Logistics Agency awarded a $47,612.95 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) units. This is a firm fixed-price contract with an ultimate completion date of September 5, 2025, and represents a competitively awarded, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. TALTZ (ixekizumab) is a biologic medication used to treat autoimmune conditions, and this procurement supports the Defense Health Agency's pharmaceutical supply requirements for military beneficiaries. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical supply needs through open competition, combined with its existing strategic position as a prime vendor for the DLA, positions it to continue serving military healthcare systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.6k | 9/4/25 |